AI technology could be a ‘game changer’ for chronic pulmonary conditions, according to Intermountain Health

June 3, 2026 - 09:26

Intermountain Health researchers have released findings from what they call a landmark study demonstrating that artificial intelligence could significantly improve the management of two widespread chronic pulmonary conditions. The research focused on chronic obstructive pulmonary disease and asthma, which together affect millions of patients and place a heavy burden on healthcare systems.

The study suggests that AI technology can streamline diagnosis, personalize treatment plans, and predict flare-ups before they become severe. According to the researchers, current methods for managing these conditions often rely on patient-reported symptoms and periodic lung function tests, which can miss early warning signs. By analyzing patterns in electronic health records, medication usage, and even environmental data, AI models may identify subtle changes that indicate a patient's condition is worsening.

Lead investigators described the potential as a "game changer" for pulmonology. They noted that earlier intervention could reduce emergency room visits and hospitalizations, which are common for patients with advanced COPD or poorly controlled asthma. The AI system is designed to support clinicians rather than replace them, offering alerts and recommendations that doctors can review and act upon.

The study team emphasized that while the results are promising, further validation is needed before widespread clinical adoption. They are now planning larger trials to test the AI tool across multiple healthcare settings. If successful, the technology could eventually be integrated into routine care, helping patients breathe easier and live more active lives.